This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Devin Quinlan: Innovator in Ebola Research
Introduction
Devin Quinlan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic solutions for viral infections.
Latest Patents
Quinlan holds a patent for "Antibodies that bind Ebola glycoprotein and uses thereof." This patent includes isolated monoclonal antibodies that specifically bind to the Ebola virus glycoprotein. The patent also outlines related antibody-based compositions and molecules, as well as therapeutic and diagnostic methods for utilizing these antibodies.
Career Highlights
Quinlan is affiliated with the Massachusetts Institute of Technology, where he engages in cutting-edge research. His work focuses on developing innovative solutions to combat viral diseases, showcasing his commitment to advancing medical science.
Collaborations
Quinlan collaborates with esteemed colleagues such as Ram Sasisekharan and Kannan Tharakaraman. Their combined expertise enhances the research efforts aimed at understanding and treating viral infections.
Conclusion
Devin Quinlan's contributions to the field of biomedical research, particularly through his patent on Ebola antibodies, highlight his role as an innovator dedicated to improving public health. His work continues to inspire advancements in therapeutic methods for combating viral diseases.